Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Public Hospitals Restructure To Meet Market Demand

This article was originally published in PharmAsia News

Executive Summary

Some public hospitals in China will undergo restructuring such that social funds and participation will help in the development of a system for medical treatment and health care services. Non-profit organizations will follow pricing regulated by the government and a unified market demand, while the rest of the autonomous hospitals are free to set their own fees. With China's health reform plan being implemented, a new framework for treatment and health care will be established by 2010. Future directions in the reform include: implementation of medical industry management; legal administration and entrepreneurship in hospitals; and practice of hospital directorship. Analysts believe the commercialization of hospitals will promote long-term improvement of China's medical system. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068059

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel